SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 29, 2000
---------------------------
BARRINGER LABORATORIES, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE
--------------------------------------------
(State or other jurisdiction of incorporation)
1-8241 84-0951626
---------------------- -------------------------------
(Commission File Number) (IRS Employer Identification No.)
15000 West 6th Avenue, Suite 300, Golden CO 80401-5047
--------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 303/277-1687
Not Applicable
-----------------------------------------------------------
(Former name or former address, if changed since last report)
1
<PAGE>
ITEM 5. OTHER EVENTS
At a Special Stockholders Meeting held on March 29, 2000, the shareholders
of Barringer Laboratories, Inc. voted in favor of increasing the number of
authorized shares of common stock from 10 million to 50 million. As indicated in
a recent Form 8-K, which was filed with the SEC on March 3, 2000, a portion of
the increased number of authorized shares will be issued to redeem convertible
debt previously issued as well as additional convertible debt to be issued as
contemplated by the company. Otherwise, there are no current plans to issue
additional shares of the company's common stock.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated: March 31, 2000
BARRINGER LABORATORIES, INC.
By: /s/ J. Graham Russell
----------------------------------
J. Graham Russell, President
2
